Kolkata, Mar 14 (UNI) GVK Biosciences (GVK BIO) today announced that it has entered into a 50:50 joint venture (JV) with INC research (INC) to form INC GVK BIO Private limited.
The joint venture will enable INC research to conduct its global clinical trials in the areas of oncology, CNS, infectious diseases and pediatrics involving phase I-IV studies. GVK BIO currently provides contract research services to a rapidly growing base of global pharmaceutial and biotechnology companies.
Commenting on the new initiative, Mr G V Sanjay Reddy, Chief executive officer,GVK BIO said,"The joint venture provides and opportunity for GVK BIO to gain access to INC research's global reach, while leveraging on its India based clinical research capabilities".
Mr Kelvin Logan ,Phd, president of INC research Europe Stated, " Our international base of operations has expanded strategically last year,with the addition of several new offices in Europe and now India. This joint venture will allow INC research to further solidify and expand its presence within the world CRO market".
UNI
The joint venture will enable INC research to conduct its global clinical trials in the areas of oncology, CNS, infectious diseases and pediatrics involving phase I-IV studies. GVK BIO currently provides contract research services to a rapidly growing base of global pharmaceutial and biotechnology companies.
Commenting on the new initiative, Mr G V Sanjay Reddy, Chief executive officer,GVK BIO said,"The joint venture provides and opportunity for GVK BIO to gain access to INC research's global reach, while leveraging on its India based clinical research capabilities".
Mr Kelvin Logan ,Phd, president of INC research Europe Stated, " Our international base of operations has expanded strategically last year,with the addition of several new offices in Europe and now India. This joint venture will allow INC research to further solidify and expand its presence within the world CRO market".
UNI
Oneindia Login